Follow this link:
GBS Inc. Announces Institutional Review Board Approval to Initiate Clinical Trial at Sutter Health Mills-Peninsula Medical Center

Read more:
SELLAS Life Sciences Signs Exclusive License Agreement with GenFleet Therapeutics for Next-Generation, Highly Selective CDK9 Inhibitor

Link:
US WorldMeds and Adamis Pharmaceuticals Announce U.S. Launch of ZIMHI™ Naloxone Product

More:
IO Biotech Announces Year-End Results for 2021

See the original post here:
ARCA biopharma Reports Topline Results for ASPEN-COVID-19 Phase 2b Clinical Trial

See the original post:
Idera Pharmaceuticals Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Corporate Update

Continue reading here:
ABVC Biopharma Announces Fiscal Year 2021 Financial and Operational Results

Continue reading here:
Adamis Pharmaceuticals Reports Full Year 2021 Financial Results and Provides Corporate Update

Continue reading here:
TransCode Therapeutics Reports 2021 Results; Provides Business Update

Read more:
BioSyent Announces Grant of Restricted Share Units

See the article here:
T2 Biosystems Announces BARDA Exercise of Contract Option 2B Valued at $4.4 Million

See more here:
Finch Therapeutics Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Business Updates

Go here to see the original:
Avicanna Announces Closing of Non-Brokered Private Placement

Follow this link:
Theratechnologies to Announce Financial Results for Its First Quarter 2022

Go here to read the rest:
Voluntary delisting of ADSs has become effective

Read more:
Timber Pharmaceuticals Provides Business Update and Announces Fourth Quarter and Year End 2021 Financial Results

More here:
Avicanna Announces Filing of Annual Financial Statements for Year Ended December 31, 2021

Read the original post:
Mydecine Reports Financial Results for the Fiscal Year 2021 and Provides a Business Update

Go here to see the original:
Hyloris Successfully Raises EUR 15.0 Million in an Equity Offering by Means of A Private Placement Via an Accelerated Bookbuild Offering

Read more:
Press Release: EUROAPI listing on Euronext Paris expected on May 6, 2022